Racial Disproportionality in Covid Clinical Trials To provide the necessary data for generalizing efficacy and safety outcomes across racial groups, Covid-19 clinical trials must prioritize inclusi...
No takes yet. Share an insight, caveat, or question.
Chastain et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: